Clover Health Investments, Corp. · NASDAQ:CLOV

Clover Health Investments — SPAC Merger (October 2020)

65 slides from Clover Health Investments's SPAC merger presentation, Oct 6, 2020

  1. Slide 1: Social Capital Hedosophia III October 2020

    SOCIAL CAPITAL HEDOSOPHIA III OCTOBER 2020 IPOC

  2. Slide 2: Total shareholder return in the last decade

    2 5.5x 4.8x 4.6x 2.9x 1.9x 1.0x S&P 500 TOTAL SHAREHOLDER RETURN IN THE LAST DECADE Note: Data sourced from FactSet; values shown relative to the S&P 500

  3. Slide 3: Technology Company

    3 TECHNOLOGY COMPANY

  4. Slide 4: Better outcomes at a lower cost

    4 BETTER OUTCOMES AT A LOWER COST

  5. Slide 5: Growing 3x faster than the industry

    5 GROWING 3X FASTER THAN THE INDUSTRY Note: Based on internal Company analysis

  6. Slide 6: Sequoia

    - SEQUOIA !: G/ Round

  7. Slide 7: An incredibly valuable company

    7 AN INCREDIBLY VALUABLE COMPANY

  8. Slide 8: Once in a generation opportunity to do the right thing

    8 ONCE IN A GENERATION OPPORTUNITY TO DO THE RIGHT THING

  9. Slide 9: Healthcare moving at software speed

    9 HEALTHCARE MOVING AT SOFTWARE SPEED

  10. Slide 10: Clover

    Clover

  11. Slide 11: Backdrop

    11 BACKDROP

  12. Slide 12: Healthcare spending in 2019 was $3.65T

    12 HEALTHCARE SPENDING IN 2019 WAS $3.65T Source: The Centers for Medicare & Medicaid Services (CMS)

  13. Slide 13: Spending per capita since 1970

    13 $0 $2,000 $4,000 $6,000 $8,000 $10,000 $12,000 1970 1974 1978 1982 1986 1990 1994 1998 2002 2006 2010 2014 2018 Total National Health Expenditures Constant 2018 Dollars +31x +6x SPENDING PER CAPITA SINCE 1970 Note: Data sourced from the Kaiser Family Foundation

  14. Slide 14: Average life expectancy

    14 AVERAGE LIFE EXPECTANCY 78.6 80.7 OECD Average Note: Data sourced from the Organisation for Economic Cooperation and Development (OECD)and World Bank

  15. Slide 15: Individuals with 2+ chronic conditions

    15 INDIVIDUALS WITH 2+ CHRONIC CONDITIONS 28% 18% 15% 14% France Aus UK Note: Data sourced from the British Medical Journal (BMJ)

  16. Slide 16: Administrative costs

    16 ADMINISTRATIVE COSTS 8.3% 5.7% 2.7% 2.0% 0.6% United States France Canada UK Norway Note: Data sourced from the Organisation for Economic Cooperation and Development (OECD) Administrative costs as a % of total health expenditures

  17. Slide 17: 81% of consumers are dissatisfied with their healthcare experience

    17 81% OF CONSUMERS ARE DISSASTISFIED WITH THEIR HEALTHCARE EXPERIENCE Source: Study commissioned by Prophet and GE Healthcare Camden Group

  18. Slide 18: Clover

    18 CLOVER

  19. Slide 19: Software that improves every interaction at the point of care

    19 SOFTWARE THAT IMPROVES EVERY INTERACTION AT THE POINT OF CARE

  20. Slide 20: Clover Assistant combines machine learning and an expert system

    20 CLOVER ASSISTANT IS A COMBINATION OF MACHINE LEARNING AND AN EXPERT SYSTEM

  21. Slide 21: Physicians use Clover Assistant to deliver better care

    21 PHYSICIANS USE CLOVER ASSISTANT TO HELP THEM DELIVER BETTER CARE TO PATIENTS

  22. Slide 22: Better outcomes for members

    22 BETTER OUTCOMES FOR MEMBERS

  23. Slide 23: Fewer ER visits and hospital admits than benchmark

    23 252 197 Benchmark Clover HOSPITAL ADMITS PER 1,000 600 465 Benchmark Clover ER VISITS PER 1,000 23% FEWER ER VISITS 22% FEWER HOSPITAL VISITS Note: Based on internal Company analysis

  24. Slide 24: Market

    24 MARKET

  25. Slide 25: Improving Medicare Advantage

    25 IMPROVING MEDICARE ADVANTAGE

  26. Slide 26: Chronic conditions among Medicare beneficiaries

    26 80% HAVE 1+ CHRONIC CONDITION 68% HAVE 2+ CHRONIC CONDITIONS Source: Study commissioned by the National Council on Aging

  27. Slide 27: Supported by Democrats and Republicans

    27 SUPPORTED BY DEMOCRATS AND REPUBLICANS

  28. Slide 28: Fast growing market

    28 FAST GROWING MARKET 25.6% 9.3% 11.8% 28.2% 12.1% 13.0% 23.8% 8.8% 12.4% 25.7% 13.2% 16.1% 0 - 18 19 - 25 26 - 34 35 - 54 55 - 64 65+ 2018 2010 POPULATION DISTRIBUTION BY AGE COHORT OVER TIME (51m) (39m) Note: Data sourced from the Kaiser Family Foundation

  29. Slide 29: Worth $270B today

    29 WORTH $270B TODAY Note: Analysis based on data from the Centers for Medicare & Medicaid Services (CMS)

  30. Slide 30: Estimated worth $590B by 2025

    30 ESTIMATED WORTH $590B BY 2025 Note: Analysis based on data from the Centers for Medicare & Medicaid Services (CMS)

  31. Slide 31: 10,000+ new people become eligible every day

    31 10,000+ NEW PEOPLE BECOME ELIGIBLE EVERYDAY Note: Analysis based on data from the Centers for Medicare & Medicaid Services (CMS)

  32. Slide 32: $150M each day, $1B each week, $55B each year

    32 $150M EACH DAY $1B EACH WEEK $55B EACH YEAR Note: Analysis based on data from the Centers for Medicare & Medicaid Services (CMS)

  33. Slide 33: Technology that delivers better outcomes at lower costs

    33 TECHNOLOGY THAT DELIVERS BETTER OUTCOMES AT LOWER COSTS

  34. Slide 34: Growth

    34 GROWTH

  35. Slide 35: Fastest growing Medicare Advantage plan in the U.S.

    35 FASTEST GROWING MEDICARE ADVANTAGE PLAN IN THE U.S. 0% 5% 10% 15% 20% 25% 30% CLOVER MEAN MEDIAN CAGR VS NEXT 9 COMPETITORS Note: Based on internal Company analysis

  36. Slide 36: Capture 50% of net membership growth in established markets

    36 CAPTURE 50% OF NET MEMBERSHIP GROWTH IN THEIR ESTABLISHED MARKETS Note: Based on internal Company analysis

  37. Slide 37: Market share growth per county

    37 25% – 5% 10% 15% 20% 25% 30% 2016 2017 2018 2019 Today MARKET SHARE GROWTH PER COUNTY Note: Based on internal Company analysis

  38. Slide 38: Superior gross margins with Clover Assistant

    38 SUPERIOR GROSS MARGINS WITH CLOVER ASSISTANT 15% 18% ? Benchmark Clover Today Clover Tomorrow JUST IN THE FIRST 18 MONTHS Returning Member Gross Margin

  39. Slide 39: 41% cheaper than Medicare

    39 41% CHEAPER THAN MEDICARE 17% CHEAPER THAN NEAREST COMPETITOR Note: Based on internal Company analysis

  40. Slide 40: Counties today, counties next year

    40 34 COUNTIES TODAY 108 COUNTIES NEXT YEAR

  41. Slide 41: Medicare Advantage members 2020E and 2021E

    41 57K MEDICARE ADVANTAGE MEMBERS 2020E 73K MEDICARE ADVANTAGE MEMBERS 2021E Note: Company forecasts

  42. Slide 42: Direct Contracting

    42 DIRECT CONTRACTING

  43. Slide 43: Provide value to Original Medicare

    43 PROVIDE VALUE TO ORIGINAL MEDICARE

  44. Slide 44: Contract directly with physicians to add thousands of lives

    44 CONTRACT DIRECTLY WITH PHYSICIANS TO ADD THOUSANDS OF LIVES THROUGH ONE CONTRACT

  45. Slide 45: Creates a low cost acquisition channel

    45 CREATES A LOW COST ACQUISITION CHANNEL TO COVER MORE LIVES

  46. Slide 46: Similar profitability as Medicare Advantage

    46 WITH SIMILAR PROFITABILITY AS MEDICARE ADVANTAGE

  47. Slide 47: 200K members already under contract for 2021

    47 200K MEMBERS ALREADY UNDER CONTRACT FOR 2021

  48. Slide 48: 450K members in 2023E

    48 450K MEMBERS IN 2023E Note: Company forecasts

  49. Slide 49: Total lives covered 2020E-2023E

    49 0 100,000 200,000 300,000 400,000 500,000 600,000 2020E 2021E 2022E 2023E Medicare Advantage (MA) Direct Contracting (DC) 200k DC lives already under contract for 2021 TOTAL LIVES COVERED Note: Based on internal Company analysis 450k DC lives covered by 2023E 139k MA Members by 2023E

  50. Slide 50: Building a virtuous cycle with compounding advantages of scale

    50 BUILDING A VIRTUOUS CYCLE WITH COMPOUNDING ADVANTAGES OF SCALE

  51. Slide 51: Virtuous cycle of data and membership growth

    51 Apply machine learning to provide data - driven, personalized insights at the point of care via the Clover Assistant Capture and synthesize data Improve clinical decision - making to drive better care Share superior economics with members via lower cost and better benefits Drive strong market lea

  52. Slide 52: Merger details

    52 MERGER DETAILS

  53. Slide 53: Transaction details

    53 Note: Pro Forma Net Cash on balance sheet includes unrestricted cash and marketable securities less corporate debt as of June 30, 2020 plus $668 mil lion of proceeds from this transaction. Transaction Details ($m) Investment from IPOC $828 PIPE / Co - Investment $400 Contribution from affiliates

  54. Slide 54: Illustrative valuation at normalized industry economics

    54 2021E 2023E UNITED, HUMANA, CENTENE MEDICARE ADVANTAGE 73,000 139,000 DIRECT CONTRACTING 200,000 450,000 TOTAL LIVES COVERED 273,000 589,000 PREMIUM/ (DISCOUNT) 13% (48%) ANNUAL REVENUE PER MEMBER/LIFE $12,000 $12,000 $12,000 ANNUAL PROFITABILITY PER MEMBER $800 $800 $800 EBITDA $218M $471M EBITD

  55. Slide 55: Illustrative future acquisition value of Clover's MA book

    55 2025E UNITED, HUMANA, CENTENE MEDICARE ADVANTAGE 323,000 DIRECT CONTRACTING 0 TOTAL LIVES COVERED 323,000 ANNUAL REVENUE PER MEMBER $12,000 $12,000 REVENUE $3.876B MERGER VALUATION $3.702B PRICE TO REVS 0.96X 1.31X ILLUSTRATIVE FUTURE ACQUISITION VALUE OF CLOVER’S MA BOOK

  56. Slide 56: Investment thesis

    56 INVESTMENT THESIS

  57. Slide 57: Clover is a technology company whose software improves outcomes and lowers costs

    57 CLOVER IS A TECHNOLOGY COMPANY WHOSE SOFTWARE ALLOWS THEM TO IMPROVE OUTCOMES AND LOWER COSTS CLOVER IS QUICKLY CAPTURING SHARE FROM INCUMBENTS AND ITS DIFFERENTIATION WILL MAKE IT HARD FOR OTHERS TO COPY DIRECT CONTRACTING SUPERCHARGES THE ENTIRE BUSINESS BY CREATING A LOW COST ACQUISITION CHANN

  58. Slide 58: Clover is the fastest growing Medicare Advantage company in the US

    58 CLOVER IS THE FASTEST GROWING MEDICARE ADVANTAGE COMPANY IN THE US MEDICARE ADVANTAGE IS THE FASTEST GROWING MARKET WITHIN HEALTHCARE WITH BROAD REGULATORY MOATS AND POLITICAL SUPPORT HEALTHCARE HAS GROWN FASTER THAN EVERYTHING INCLUDING BIG TECH

  59. Slide 59: Growth * Growth * Growth

    59 GROWTH * GROWTH * GROWTH

  60. Slide 60: Team

    60 TEAM

  61. Slide 61: Better vs different

    61 BETTER VS DIFFERENT

  62. Slide 62: Vivek Garipalli CEO and Founder, Andrew Toy President & CTO

    62 Vivek Garipalli CEO and Founder Andrew Toy President & CTO

  63. Slide 63: IPOC + Clover

    iPOC + Clover 83

  64. Slide 64: Fin

    64 FIN

  65. Slide 65: Disclaimer

    65 DISCLAIMER Confidentiality and Disclosures This presentation has been prepared for use by Social Capital Hedosophia Holdings Corp. III (“Social Capital”) and Clover Health LLC (“Clover”) in connection with their proposed business combination. This presentation is for information purposes only and

Clover Health — SPAC Merger (October 2020) on 6ix